Skip Ribbon Commands
Skip to main content

​​​​The Collaboration for TB Vaccine Discovery (CTVD) is an international network of scientists and experts dedicated to fostering innovation, cooperation, and collaboration in the up-stream TB vaccine discovery space.
​

Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis. While effective diagnosis and treatment has saved millions of lives, TB is still the ninth leading cause of death worldwide and the leading cause from a single infectious agent.
 


Currently, there is only one vaccine against tuberculosis available worldwide: Bacille Calmette- Gutuberculosis. However, BCG has little to no efficacy in preventing pulmonary TB in adolecents and adults.



We are an international network of scientists and experts dedicated to fostering innovation and collaboration in the up-stream TB vaccine discovery and development space. Our goal is to accelerate discovery and development of a vaccine to prevent TB infection and disease in adolescents and adults.
​

We believe that scientific exchange is essential to ensuring the TB field remains innovative. The Visiting Scientist Program (VSP) enables scientists from different CTVD member institutions to embrace new scientific concepts and gain experience in novel technologies with an overarching goal of promoting the exchange of ideas, expertise, and experiences.
 

Joel Ernst
Musa Mhlanga
Mohau Steven Makatsa
Anele Gela
University of California San Francisco, US University of Cape Town, South Africa University of Cape Town, South Africa South African Tuberculosis Vaccine Initiative, University of Cape Town​​​​​​​​​​​​​​